Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Wyeth Research Division of Wyeth Pharmaeuticals Inc. (A Pfizer Company)

Femme et Homme Max 99 ans
Wyeth Research Division of Wyeth Pharmaeuticals Inc. (A Pfizer Company) MAJ Il y a 4 ans

A Phase I/II Safety and Exploratory Pharmacodynamic Study of Intravenous Temsirolimus (CCI-779) in Pediatric Subjects with Relapsed/Refractory Solid Tumors Part 1 (Part 1 is now closed): Primary Objective - To evaluate the safety of IV temsirolimus given once weekly to children with solid tumors with disease that is recurrent or refractory to standard th...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations